Usefulness of Lidocaine in Oral and Maxillofacial Surgeries Under General Anesthesia for Pain Control After Operation
Status:
Completed
Trial end date:
2019-03-27
Target enrollment:
Participant gender:
Summary
This will be a randomized double blinded clinical study conducted in patients undergoing oral
and maxillofacial surgery under general anesthesia. Lidocaine group will receive intravenous
bolus 1.5 mg/kg at induction followed by continuous infusion of 2 mg/kg/hr until the
completion of surgery.Normal saline group will receive same amount of intravenous normal
saline .The primary outcome will be postoperative pain using the NRS scale during first 24
hours and time to first analgesic request